Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04237701

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases Heart Failure NYHA Class IV Heart Failure With Preserved Ejection Fraction Heart Failure With Reduced Ejection Fraction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Yale New Haven Health System

New Haven, Connecticut, 06510, United States

Location status: Recruiting

Location contact

Nihar Desai, MD MPH

CONTACT

[email protected]

2037676399

Nihar Desai, MD MPH

PRINCIPAL_INVESTIGATOR

Tariq Ahmad, MD MPH

CONTACT

[email protected]

203-843-1667

Tariq Ahmad, MD MPH

PRINCIPAL_INVESTIGATOR

About this study

Electronic Health Records based registries can be an important resource for precision medicine delivery by understanding the population burden of chronic diseases such as heart failure. These registries can allow for a deeper understanding of gaps in guideline recommended therapies among patients who are under the purview of large, integrated Therefore, we have created a live registry within the integrated Yale New Haven Health System-the Yale Heart Failure Registry-that includes all patients with a diagnosis of HF and has detailed information about demographics, comorbidities, laboratories, imaging, medications, and clinical outcomes (including hospital readmissions). The registry is updated daily and can be queried for clinically relevant questions aimed at quality improvement.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Seen within the Yale New Haven Health System
  • Diagnosis of heart failure

Exclusion criteria

  • Age<18

Treatment and study plan

Primary outcomes

  1. Number of participants hospitalized for heart failure

    Time frame: 10 years

    Heart Failure hospitalizations

  2. Doses of therapies that comprise guideline directed medical therapy

    Time frame: 10 years

    Appropriate use of guideline recommended therapies. This will include doses of beta blockers, ACE inhibitors, ARBs, ARNI, SGLT2i, ICD use.

Study contacts

Contact information is provided by the study sponsor or research team.

Nihar Desai, MD MPH

CONTACT

203-767-6399

Tariq Ahmad, MD MPH

CONTACT

[email protected]

(203) 843-1667

Sponsors and collaborators

Lead sponsor

Yale University

Other

Registry information

Official study title

Retrospective and Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System Via a Live Registry

Acronym: Yale-HF

Important dates

Study start
2019
Primary completion
2030
Study completion
2030
First posted
Jan 23, 2020
Registry last updated
Mar 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.